Chennai Meenakshi Multispeciality Hospital Releases Q1 Financial Results: Mixed Performance and Potential Concerns

Aug 13 2024 06:33 PM IST
share
Share Via
Chennai Meenakshi Multispeciality Hospital's financial results for the quarter ending March 2024 show a flat performance with a score of -1. The company's Debtors Turnover Ratio is the highest in the last five half-yearly periods, indicating efficient debt management. However, there are concerns with the lowest Operating Profit and efficiency, and a negative trend for Profit Before Tax. Investors and experts should consider these factors before making any investment decisions.

Chennai Meenakshi Multispeciality Hospital, a microcap healthcare services company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' call by MarketsMOJO.

According to the financial report, Chennai Meena's performance for the quarter has been flat, with a score of -1 compared to 1 in the previous quarter. However, there are some positive aspects to the company's financials. The Debtors Turnover Ratio for the last five half-yearly periods has been the highest at 51.86 times, indicating that the company has been able to settle its debtors faster.

On the other hand, there are also some areas of concern for Chennai Meena. The Operating Profit (PBDIT) for the quarter is at its lowest in the last five quarters, at Rs 0.06 crore. The company's efficiency has also deteriorated, with the Operating Profit Margin at its lowest in the last five quarters at 0.69%. Additionally, the Profit Before Tax less Other Income (PBT) for the quarter is at its lowest in the last five quarters, at Rs -0.49 crore. The near-term trend for PBT is also negative.

Investors and experts are advised to take note of these financial results and make informed decisions regarding their investments in Chennai Meenakshi Multispeciality Hospital. The company's performance in the quarter ending March 2024 may have an impact on its stock price and future prospects.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News